InflaRx (IFRX) Interest Expenses (2016 - 2026)
InflaRx's (IFRX) quarterly Interest Expenses came in at -$17020.5 in Q2 2026, down 348.18% year-over-year from $6858.2 in Q2 2025, and up 1.83% quarter-over-quarter from -$17337.6 in Q1 2026.
Analysis
InflaRx (IFRX) Interest Expenses (2016 - 2026) Analysis & Trends
InflaRx has disclosed Interest Expenses across 11 years of filings, most recently posting -$17020.5 for Q2 2026.
- In Q2 2026, Interest Expenses fell 348.18% year-over-year to -$17020.5; the TTM figure through Jun 2026 stood at -$71444.3 (down 100.16% YoY), while the FY2025 annual figure was -$44332.7, down 100.86% from the prior year.
- Interest Expenses came in at -$17020.5 for Q2 2026 at InflaRx, up from -$17337.6 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of -$3797.7 in Q2 2025 to a low of -$46166.2 in Q4 2022.
- Average Interest Expenses over 5 years is -$14767.3, with a median of -$8940.6 recorded in 2022.
- Year-over-year, Interest Expenses sank 520.95% in 2022 and jumped 78.5% in 2023.
- Over 5 years, Interest Expenses stood at -$46166.2 in 2022, then increased by 16.97% to -$38333.6 in 2023, then jumped by 42.42% to -$22071.8 in 2024, then rose by 8.03% to -$20299.8 in 2025, then climbed by 16.15% to -$17020.5 in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were -$17020.5 in Q2 2026, -$17337.6 in Q1 2026, and -$20299.8 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 673.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 247.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 11.00 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -1.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn | -17,020.46 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17,020.46 |
| Mar 31, 2026 | -17,337.57 |
| Dec 31, 2025 | -20,299.75 |
| Sep 30, 2025 | -16,786.46 |
| Jun 30, 2025 | -3,797.72 |
| Mar 31, 2025 | -4,298.00 |
| Dec 31, 2024 | -22,071.84 |
| Sep 30, 2024 | -5,526.24 |
| Jun 30, 2024 | -9,403.38 |
| Mar 31, 2024 | -5,032.03 |
| Dec 31, 2023 | -38,333.59 |
| Sep 30, 2023 | -5,330.83 |
| Jun 30, 2023 | -5,501.25 |
| Mar 31, 2023 | -5,933.43 |
| Dec 31, 2022 | -46,166.19 |
| Sep 30, 2022 | -6,901.64 |
| Jun 30, 2022 | -8,477.77 |
| Mar 31, 2022 | -27,593.80 |
| Dec 31, 2021 | -28,335.02 |
| Sep 30, 2021 | -11,235.07 |